Fisher & Paykel Healthcare logo

FPH - Fisher & Paykel Healthcare News Story

NZD33.8 -0.1  -0.3%

Last Trade - 6:00am

Large Cap
Market Cap £10.03bn
Enterprise Value £10.01bn
Revenue £825.8m
Position in Universe 31st / 1911

NZ's Fisher & Paykel Healthcare upgrades guidance on weaker local currency

Thu 23rd August, 2018 2:50am
Aug 23 (Reuters) - New Zealand medical device firm Fisher &
Paykel Healthcare       FPH.NZ  on Thursday raised its full-year
profit guidance by more than two percent as it benefited from a
weakening in the New Zealand dollar.
    The firm, which generates a majority of its revenue outside
New Zealand, now expected annual net profit of about NZ$215
million ($142.67 million), higher than its previous guidance of
about NZ$210 million. 
    "This year, the New Zealand dollar has weakened against a
number of other currencies, which is the major contributor to
the upgrade in our earnings guidance," Managing Director and CEO
Lewis Gradon said. 
     The New Zealand dollar  NZD=D3  has fallen more than 5
percent so far in 2018.   
    The company also upgraded its operating revenue guidance to
about NZ$1.07 billion, compared to a previous forecast of about
NZ$1.05 billion.
($1 = 1.5069 New Zealand dollars)

 (Reporting by Aditya Soni in Bengaluru
Editing by Darren Schuettler)
 ((; +91 80 6749 1783; Reuters
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.